CATALOGO DEI PRODOTTI DELLA RICERCA

PESARINI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.704
EU - Europa 2.595
AS - Asia 2.296
SA - Sud America 274
AF - Africa 55
OC - Oceania 6
Totale 7.930
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.663
SG - Singapore 910
CN - Cina 819
GB - Regno Unito 807
IT - Italia 343
HK - Hong Kong 288
RU - Federazione Russa 258
BR - Brasile 250
FR - Francia 235
DE - Germania 234
SE - Svezia 214
IE - Irlanda 185
FI - Finlandia 179
KR - Corea 96
UA - Ucraina 35
TG - Togo 30
VN - Vietnam 25
BE - Belgio 19
CA - Canada 19
IN - India 19
TR - Turchia 18
NL - Olanda 16
JP - Giappone 15
ID - Indonesia 12
IR - Iran 11
AT - Austria 10
BD - Bangladesh 10
IQ - Iraq 10
MA - Marocco 10
MX - Messico 10
PL - Polonia 9
ZA - Sudafrica 9
KG - Kirghizistan 8
AR - Argentina 7
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
PK - Pakistan 7
CH - Svizzera 6
ES - Italia 6
IL - Israele 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
LT - Lituania 4
PT - Portogallo 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
LV - Lettonia 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AU - Australia 2
BH - Bahrain 2
BZ - Belize 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SI - Slovenia 2
TJ - Tagikistan 2
BY - Bielorussia 1
CD - Congo 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MZ - Mozambico 1
NC - Nuova Caledonia 1
NG - Nigeria 1
RE - Reunion 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
UY - Uruguay 1
Totale 7.930
Salva come PNG Salva come JPEG
Città #
Southend 742
Singapore 397
Dallas 379
Chandler 368
Hong Kong 287
Jacksonville 224
Ashburn 217
Dublin 184
Beijing 167
New York 127
Munich 97
Woodbridge 96
Helsinki 92
Ann Arbor 82
Verona 82
Jinan 66
Houston 62
Lawrence 58
Princeton 58
The Dalles 54
Wilmington 52
Shenyang 49
Nanjing 37
Hebei 34
Los Angeles 34
Turku 32
Milan 31
Lomé 30
Santa Clara 30
Seattle 30
Tianjin 29
Columbus 26
Sindelfingen 26
Seoul 25
Nanchang 23
Taizhou 23
Changsha 22
Frankfurt am Main 22
Zhengzhou 22
Cedar Knolls 21
Haikou 20
Brussels 19
Taiyuan 18
Moscow 17
Ningbo 17
Rome 17
Washington 17
Kent 16
São Paulo 16
Hangzhou 15
Nuremberg 13
Redwood City 13
Brooklyn 12
Guangzhou 12
Jiaxing 12
San Francisco 12
Tokyo 12
Fairfield 11
Norwalk 11
Amsterdam 10
Falkenstein 10
Lanzhou 10
Lappeenranta 10
Belo Horizonte 9
Boston 9
Fuzhou 9
Jakarta 9
London 9
Montreal 9
Ho Chi Minh City 8
Lancaster 8
Phoenix 8
Bishkek 7
Brasília 7
Chennai 7
Chicago 7
Council Bluffs 7
Rio de Janeiro 7
Toronto 7
Turin 7
Vienna 7
Warsaw 7
Baku 6
Bologna 6
Buffalo 6
Curitiba 6
Porto Alegre 6
Romola 6
Shanghai 6
Venice 6
Zanjan 6
Atlanta 5
Cagliari 5
Denver 5
Paris 5
Redmond 5
Stockholm 5
Zurich 5
Ankara 4
Baghdad 4
Totale 5.002
Salva come PNG Salva come JPEG
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 510
MODULAZIONE DELLA RISPOSTA INFIAMMATORIA NELLA PREVENZIONE DELLA RESTENOSI POST STENT CORONARICO: IL TRIAL CLINICO MULTICENTRICO RANDOMIZZATO “CEREA-DES” 168
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 125
Hemodynamic predictors of long term survival in end stage cystic fibrosis 125
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 124
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 118
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 117
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 116
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 116
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 115
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 113
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 113
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 112
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 111
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 110
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 108
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 108
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 106
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 105
Risk stratification in acute coronary syndromes. 105
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 105
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 102
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 102
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 101
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 101
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 99
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 98
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 95
Comparison of the long-term survival benefits associated with revascularization or medical therapy in patients with known coronary artery disease undergoing transesophageal atrial pacing stress echocardiography 95
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 95
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 93
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 91
Acute electrocardiographic differences between Takotsubo cardiomyopathy and anterior ST elevation myocardial infarction 89
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 89
Impella-protected PCI: the clinical results achieved so far 88
Long-term variations of FFR and iFR after transcatheter aortic valve implantation 87
Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery 86
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 86
First Observation of a "Golden Tube" After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft Vasculopathy 85
New-onset extreme right axis deviation in acute myocardial infarction: clinical characteristics and outcomes 85
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 85
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 84
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 83
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. 83
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 82
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry. 82
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 79
Early shifts in serum creatinine concentrations can predict contrast-induced nephropathy and persistent renal damage following angiography,Modificazioni precoci nella concentrazione della creatininemia sono in grado di predire la nefropatia da mezzo di contrasto e il danno renale persistente dopo angiografia 79
Extravalvular Cardiac Damage and Renal Function Following Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis 77
Recurrent very late drug-eluting stent thrombosis. 76
Percutaneous Impella Recover circulatory support in high-risk coronary angioplasty. 75
Transapical mitral valve-in-valve procedure with elective venoarterial ECMO in a patient with severe kyphoscoliosis 75
Letter by Ribichini et al regarding article, "Cystatin C and contrast-induced acute kidney injury". 74
Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient 73
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 70
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 68
Dynamic changes of repolarization abnormalities in takotsubo cardiomyopathy 67
Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study 65
Angiography-derived index of microvascular resistance in takotsubo syndrome 64
Osteomyelitis of the clavicle following to a pacemaker implantation 59
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 58
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 58
Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact 57
Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction 57
Intraventricular entrapment of a Sapien-3 balloon in transapical TAVR: A near missed catastrophe 56
Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques 55
Bail-out transcatheter aortic valve implantation to reduce severe acute aortic regurgitation in a failing homograft secondary to HeartMate II ventricular assistance device 55
Coronary obstruction after transcatheter aortic valve replacement combined with basilica procedure 53
Choosing transcatheter aortic valve replacement in porcelain aorta: outcomes versus surgical replacement 53
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 52
Radial artery occlusion after transradial procedures: impact on 1-year adverse events 52
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI 51
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes 50
Transcatheter edge-to-edge mitral valve repair: what is the measure of success? 50
Predictors of patent and occlusive hemostasis after transradial coronary procedures 50
Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients 47
Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease 47
Significant Drop in Right Atrial Pressure Does Not Influence Fractional Flow Reserve Coronary Assessment 47
Is transfemoral aortic valve implantation possible without contrast medium in patients with renal and multiorgan failure? 45
Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions 44
Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES) 44
Right Ventricle Pulmonary Artery Coupling and Renal Function in Patients With Severe Aortic Stenosis Undergoing TAVR 44
The Influence of Aortic Valve Obstruction on the Hyperemic Intracoronary Physiology: Difference Between Resting Pd/Pa and FFR in Aortic Stenosis 44
Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation 44
Ten-Year Experience with Endomyocardial Biopsy after Orthotopic Heart Transplantation: Comparison between Trans-Jugular and Trans-Femoral Approach 43
The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions 43
Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience 43
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 42
Early Postoperative Thrombosis of Transcatheter Aortic Valve-in-Valve Prosthesis 42
Transapical Transcatheter Aortic Valve Replacement: A Real-World Early and Mid-Term Outcome of a Third-Level Centre 42
Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry 42
Quality of Life after Transcatheter Aortic Valve Replacement in Sarcopenic Patients Using the Toronto Aortic Stenosis Quality of Life Questionnaire 41
Ten-year experience with a transapical approach for transcatheter aortic and mitral valve implantation 40
Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction 40
Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track" 39
Integrated Assessment of Computational Coronary Physiology From a Single Angiographic View in Patients Undergoing TAVI 37
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART) 36
Real World Performance Evaluation of Transcatheter Aortic Valve Implantation 34
Clinical Updates in Coronary Artery Disease: A Comprehensive Review 33
Early and late clinical outcomes of endovascular, surgical, and hybrid revascularization strategies of combined carotid and coronary artery diseases: the FRIENDS study group (Finalized Research In ENDovascular Strategies) 32
Totale 7.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.238
article - articoli 37.842
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 396
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021474 0 0 75 83 92 62 15 19 22 51 47 8
2021/2022431 47 117 5 41 7 5 2 19 16 11 53 108
2022/20231.221 68 179 103 156 92 289 49 68 150 13 36 18
2023/20241.013 22 58 77 125 99 227 48 84 10 69 157 37
2024/20252.325 104 117 103 395 163 113 75 106 369 178 190 412
2025/20261.047 466 278 303 0 0 0 0 0 0 0 0 0
Totale 8.044